Clinical Trial: Human Umbilical Cord Blood (RegeneCyte) Infusion in Patients With Post-COVID Syndrome
Study Status: Completed
Recruit Status: RECRUITING
Condition: Long COVID
Study Type: INTERVENTIONAL
Official Title: A Randomized Controlled Phase IIa, Two-arm Study to Assess the Safety and Efficacy of Human Umbilical Cord Blood (RegeneCyte) Infusion in Patients With Post-COVID Syndrome
Brief Summary:
RegeneCyte (HPC, Cord Blood, hUCB) for treatment in patients with post-COVID.
Read more